TMU is hosting the 2nd International Symposium on Drug Discovery which will take place from July 2nd to 3rd, 2024 at the International Conference Hall, Xinyi Campus, Taipei Medical University, Taipei, Taiwan.
Key themes this year include novel drug discovery, druggable targets, structure-based drug design, nanocarriers, antivirals, cancer therapeutics, natural bioactives, drug development, experimental medicines, among others.
Date & time:
8:45 – 16:00, July 2nd, 2024
9:00 – 16:40, July 3rd, 2024
Location:
The International Conference Hall
16F, Comprehensive Medical Building (Rear Building), Xinyi Campus, Taipei Medical University
Day 1
Time |
Topic/ Event |
Speaker/Presenter |
8:45-9:00 |
Registration | |
9:00-9:05 |
Introducing President Mai-Szu Wu | Liang-Tzung Lin (Taipei Medical University) |
9:05-9:20 |
Opening Remarks | Mai-Szu Wu, President (Taipei Medical University) |
9:20-9:30 |
Group Photo | |
9:30-9:40 |
Introduction
Targeting unmet needs in drug development through the Drug Discovery Consortium |
Liang-Tzung Lin (Taipei Medical University) |
9:40-10:10 |
Keynote lecture Development of novel agents acting as RNA virus inhibitors targeted to both viral and cellular proteins |
Enzo Tramontano (University of Cagliari) |
10:10-10:40 | Keynote lecture A ligand-based approach for the design of multi-action anti-Alzheimer compounds |
Patricia Melnyk (University of Lille) |
10:40-11:00 | Coffee Break | |
11:00-11:30 |
Identification of compounds against ceftriaxone-resistant nontyphoidal Salmonella by Ultra-High Throughput Screening and exploration of the antibacterial effect and potential mechanism of its derivatives | Shiuh-Bin Fang (Taipei Medical University) |
11:30-12:00 |
AI-Driven Drug Design Platform for the Discovery and Optimization of Novel Kinase Inhibitors | Huang-Ju Tu (Taipei Medical University) |
12:00-13:30 |
Lunch | |
13:30-14:00 |
Metabolic Flexibility Unveiled: Novel Nutritional Insights | Sebastiano Banni (University of Cagliari) |
14:00-14:30 |
Development of lncRNA-Based Liquid Biopsy Platforms and Antisense Oligonucleotide Therapeutics for Early Detection and Treatment of Oral Squamous Cell Carcinoma | Jing-Wen Shih (Taipei Medical University) |
14:30-15:00 |
Coffee Break | |
15:00-15:30 |
Bicontinuous cubic liquid crystalline nanoparticles for anticancer photodynamic therapy | Sergio Murgia (University of Cagliari) |
15:30-16:00 | The application of multi-omics in medical research | Chih-Yang Wang (Taipei Medical University) |
Day 2
Time |
Topic |
Speaker/Presenter |
9:15-9:30 | Registration | |
09:30 | Opening | Liang-Tzung Lin (Taipei Medical University) |
9:30-10:00 | Natural product-inspired GABA receptor complex modulators |
Filippo Cottiglia |
10:00-10:30 |
New Immunosensitizer for Treatment of Colorectal cancer |
Jing-Ping Liou |
10:30-11:00 |
Coffee Break |
|
11:00-11:30 | In-silico approaches applied to studying potential Flaviviruses NS3 protease/helicase binders. | Antonio Lupia (University of Cagliari) |
11:30-12:00 | Pharmacogenomic and network analysis of THSG effects on the Oxaliplatin induced cardiac cell damage | Tien-Yuan Wu (Taipei Medical University) |
12:00-13:30 |
Lunch |
|
13:30-14:00 | Cellular and Molecular Bases of Cancer and Tissue Regeneration during aging: elucidating mechanisms and devising strategies for intervention. | Fabio Marongiu (University of Cagliari) |
14:00-14:30 | A drug discovery campaign to expand the application horizons of PARP inhibitors as cancer therapeutics | Kunal Nepali (Taipei Medical University) |
14:30-15:00 | Coffee Break | |
15:00-15:30 | Transforming molecules into medicines with drug delivery nanotechnologies: case studies on lipid-based nanoparticles | Michele Schlich (University of Cagliari) |
15:30-16:00 | Synergistic Effect of Chemovirotherapy Using Pathway-Targeted Small Compounds in Combination with Oncolytic Measles Vectors for Anticancer Treatment of Glioblastoma Multiforme | Shu-Hui Wong (Taipei Medical University) |
16:00-16:10 |
Closing Remarks |
Liang-Tzung Lin (Taipei Medical University) |